Shelter Pharma Receives International Purchase Orders
ECONOMY & POLICY

Shelter Pharma Receives International Purchase Orders

Shelter Pharma Limited (Shelter Pharma) has informed the stock exchange that it received significant export purchase orders from Genet International. The intimation was filed under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements and was dated 27 July 2026. The orders were received in the normal course of business and will be executed as per mutually agreed timelines.

The purchase orders, valued in United States dollar (USD), cover supply of veterinary feed supplements including Feedmin Bolus (2000 boxes at USD2,700), RegulIn Bolus (2500 boxes at USD3,375), Lactocal Gel (1200 pieces at USD3,360) and Buta-B Bolus (1500 boxes at USD2,850). The company has appended detailed order specifications and product-wise quantities and values in the annexure to the filing. Execution will follow the purchase order schedule and applicable export compliance procedures.

The aggregate consideration for the orders is USD12,285. The buyer is an international entity and the company has described the transaction as a normal course commercial sale. The promoters and promoter group have no interest in the buyer and the transaction does not constitute a related party transaction. The filing also states that the transaction is not conducted at arm's length basis.

Shelter Pharma indicated that the execution of the export orders is expected to strengthen its global presence and support its export business and revenue growth. The company has requested that the exchange take the filing on record; the notice bears the signature of the managing director and is dated 27 July 2026 from Ahmedabad. The company noted that such orders are in line with its strategy to deepen international engagement and to diversify export markets, and it will monitor progress against the delivery schedule.

Shelter Pharma Limited (Shelter Pharma) has informed the stock exchange that it received significant export purchase orders from Genet International. The intimation was filed under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements and was dated 27 July 2026. The orders were received in the normal course of business and will be executed as per mutually agreed timelines. The purchase orders, valued in United States dollar (USD), cover supply of veterinary feed supplements including Feedmin Bolus (2000 boxes at USD2,700), RegulIn Bolus (2500 boxes at USD3,375), Lactocal Gel (1200 pieces at USD3,360) and Buta-B Bolus (1500 boxes at USD2,850). The company has appended detailed order specifications and product-wise quantities and values in the annexure to the filing. Execution will follow the purchase order schedule and applicable export compliance procedures. The aggregate consideration for the orders is USD12,285. The buyer is an international entity and the company has described the transaction as a normal course commercial sale. The promoters and promoter group have no interest in the buyer and the transaction does not constitute a related party transaction. The filing also states that the transaction is not conducted at arm's length basis. Shelter Pharma indicated that the execution of the export orders is expected to strengthen its global presence and support its export business and revenue growth. The company has requested that the exchange take the filing on record; the notice bears the signature of the managing director and is dated 27 July 2026 from Ahmedabad. The company noted that such orders are in line with its strategy to deepen international engagement and to diversify export markets, and it will monitor progress against the delivery schedule.

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code